408 related articles for article (PubMed ID: 28148307)
1. Intrathecal Th17- and B cell-associated cytokine and chemokine responses in relation to clinical outcome in Lyme neuroborreliosis: a large retrospective study.
Gyllemark P; Forsberg P; Ernerudh J; Henningsson AJ
J Neuroinflammation; 2017 Feb; 14(1):27. PubMed ID: 28148307
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal Th17-driven inflammation is associated with prolonged post-treatment convalescence for patients with Lyme neuroborreliosis.
Gyllemark P; Sjöwall J; Forsberg P; Ernerudh J; Henningsson AJ
Sci Rep; 2023 Jun; 13(1):9722. PubMed ID: 37322136
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of cytokines and chemokines in lyme neuroborreliosis.
Cerar T; Ogrinc K; Lotric-Furlan S; Kobal J; Levicnik-Stezinar S; Strle F; Ruzić-Sabljic E
Clin Vaccine Immunol; 2013 Oct; 20(10):1578-84. PubMed ID: 23945160
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid cytokines in Lyme neuroborreliosis.
Pietikäinen A; Maksimow M; Kauko T; Hurme S; Salmi M; Hytönen J
J Neuroinflammation; 2016 Oct; 13(1):273. PubMed ID: 27756335
[TBL] [Abstract][Full Text] [Related]
5. Cytokines and chemokines in cerebrospinal fluid in relation to diagnosis, clinical presentation and recovery in children being evaluated for Lyme neuroborreliosis.
Skogman BH; Lager M; Brudin L; Jenmalm MC; Tjernberg I; Henningsson AJ
Ticks Tick Borne Dis; 2020 May; 11(3):101390. PubMed ID: 32019724
[TBL] [Abstract][Full Text] [Related]
6. Indications of Th1 and Th17 responses in cerebrospinal fluid from patients with Lyme neuroborreliosis: a large retrospective study.
Henningsson AJ; Tjernberg I; Malmvall BE; Forsberg P; Ernerudh J
J Neuroinflammation; 2011 Apr; 8():36. PubMed ID: 21507218
[TBL] [Abstract][Full Text] [Related]
7. The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis.
Henningsson AJ; Lager M; Brännström R; Tjernberg I; Skogman BH
Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1983-1991. PubMed ID: 30083887
[TBL] [Abstract][Full Text] [Related]
8. Neuroimmunomodulators in Neuroborreliosis and Lyme Encephalopathy.
Eckman EA; Pacheco-Quinto J; Herdt AR; Halperin JJ
Clin Infect Dis; 2018 Jun; 67(1):80-88. PubMed ID: 29340592
[TBL] [Abstract][Full Text] [Related]
9. Subclinical Lyme borreliosis is common in south-eastern Sweden and may be distinguished from Lyme neuroborreliosis by sex, age and specific immune marker patterns.
Carlsson H; Ekerfelt C; Henningsson AJ; Brudin L; Tjernberg I
Ticks Tick Borne Dis; 2018 Mar; 9(3):742-748. PubMed ID: 29502989
[TBL] [Abstract][Full Text] [Related]
10. B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination.
Kothur K; Wienholt L; Tantsis EM; Earl J; Bandodkar S; Prelog K; Tea F; Ramanathan S; Brilot F; Dale RC
PLoS One; 2016; 11(2):e0149411. PubMed ID: 26919719
[TBL] [Abstract][Full Text] [Related]
11. Chemokine CXCL13 concentration in cerebrospinal fluid in patients with neuroborreliosis--own observations.
Kępa L; Oczko-Grzesik B; Sobala-Szczygieł B; Boroń-Kaczmarska A
Przegl Epidemiol; 2015; 69(4):705-10, 851-5. PubMed ID: 27139348
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis.
Henningsson AJ; Gyllemark P; Lager M; Skogman BH; Tjernberg I
APMIS; 2016 Nov; 124(11):985-990. PubMed ID: 27651242
[TBL] [Abstract][Full Text] [Related]
13. Discriminating between Lyme neuroborreliosis and other central nervous system infections by use of biomarkers CXCL13 and IL-6.
Leth TA; Dessau RB; Møller JK
Ticks Tick Borne Dis; 2022 Sep; 13(5):101984. PubMed ID: 35709639
[TBL] [Abstract][Full Text] [Related]
14. CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.
Ljøstad U; Mygland A
J Neurol; 2008 May; 255(5):732-7. PubMed ID: 18344056
[TBL] [Abstract][Full Text] [Related]
15. The B-lymphocyte chemokine CXCL13 in the cerebrospinal fluid of children with Lyme neuroborreliosis: associations with clinical and laboratory variables.
Barstad B; Tveitnes D; Dalen I; Noraas S; Ask IS; Bosse FJ; Øymar K
Infect Dis (Lond); 2019; 51(11-12):856-863. PubMed ID: 31573360
[No Abstract] [Full Text] [Related]
16. CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA.
Markowicz M; Schötta AM; Kundi M; Bogovič P; Ogrinc K; Strle F; Stanek G
Ticks Tick Borne Dis; 2018 Jul; 9(5):1137-1142. PubMed ID: 29705691
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis.
Tjernberg I; Henningsson AJ; Eliasson I; Forsberg P; Ernerudh J
J Infect; 2011 Feb; 62(2):149-58. PubMed ID: 21087629
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid CXCL13 as a diagnostic marker of neuroborreliosis in children: a retrospective case-control study.
Remy MM; Schöbi N; Kottanattu L; Pfister S; Duppenthaler A; Suter-Riniker F
J Neuroinflammation; 2017 Aug; 14(1):173. PubMed ID: 28859668
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal Fluid B-lymphocyte Chemoattractant CXCL13 in the Diagnosis of Acute Lyme Neuroborreliosis in Children.
Barstad B; Tveitnes D; Noraas S; Selvik Ask I; Saeed M; Bosse F; Vigemyr G; Huber I; Øymar K
Pediatr Infect Dis J; 2017 Dec; 36(12):e286-e292. PubMed ID: 28661964
[TBL] [Abstract][Full Text] [Related]
20. [CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine].
Rupprecht TA; Lechner C; Tumani H; Fingerle V
Nervenarzt; 2014 Apr; 85(4):459-64. PubMed ID: 24682168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
